LEVANTIS-0087A (LEV87A) is a retrospective population cohort-based nested case-control study to validate the performance of the free GAGome-based MCED tests in adults asymptomatic for cancer with no recent history of cancer.
LEVANTIS-0093A (LEV93A) is a prospective observational cohort study to validate the performance of the plasma free GAGome MCED test in 55 to 80 years old adults with significant smoking history and thus at high risk of developing cancer (“high-risk adults”).
LEVANTIS-0065 (LEV65) is a prospective observational cohort study to explore the performance of the combined free GAGome MCED test in adults who are actively employed as firefighters in comparison to other MCED tests.
AURORAX-0087A (AUR87A) is a prospective multi-center observational cohort study to validate the performance of the urine free GAGome RCC test for the early detection of recurrence after curative intent surgery in patients with high or intermediate risk clear cell renal cell carcinoma.
AURORAX-0093A (AUR93A) is a prospective observational cohort study to develop free GAGome-based tests for the prognosis of muscle-invasive bladder cancer patients elected for neo-adjuvant chemotherapy before radical cystectomy.
This study aims to collect urine samples from healthy people to understand the best conditions for Elypta's test regarding how urine samples are taken, processed, and stored.
